<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03271580</url>
  </required_header>
  <id_info>
    <org_study_id>2017H0010</org_study_id>
    <nct_id>NCT03271580</nct_id>
  </id_info>
  <brief_title>Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing</brief_title>
  <official_title>Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sashwati Roy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim is to study the microenvironment of chronic biofilm infection in diabetic wounds
      which shows deregulated immune cells responses and biofilm interaction resulting in
      delayed/impaired/non wound healing. We seek to understand immune evasion strategy of biofilms
      and study mechanisms which biofilm modify macrophages phenotype and functions in such wounds
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific Objective:

        1. Determine if functionally active macrophage isolated from biofilm-infected diabetic
           wounds show extra cellular matrix degrading phenotype causing wound collagen degradation

        2. Understand by investigating whether increased presence of ECM degrading wound macrophage
           phenotypes in biofilm infected human diabetic wounds are associated with reduced wound
           collagen levels and increased wound recurrence End goal will be to understand the
           mechanism in which biofilm modulates the wound macrophage phenotype and function
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">February 5, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assess macrophage phenotype and functional modification due to biofilm infection in diabetic patients</measure>
    <time_frame>One and half year for complete results</time_frame>
    <description>Wound tissue macrophage will undergo a series of laboratory studies including: flow cytometry, Immunophnotyping, cytokine assays (pg/ml), and ELISA (pg/ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterize difference between wound macrophages and macrophages derived from peripheral blood in diabetic patients</measure>
    <time_frame>One and half year</time_frame>
    <description>Mechanism responsible for downregulated wound inflammatory cell function in patients with diabetes.This will be assessed through immunohistochemistry (IHC) and scanning electron microscopy (SEM).</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Wound</condition>
  <condition>Bacterial Infections</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Infected Ulcer of Skin</condition>
  <arm_group>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <description>Diabetic patients with HbA1c&lt;9 with who have wound 4weeks or longer with infection with following interventions:
Finger prick test for HbA1c measurement
Punch biopsy
VAC sponge collection
Ankle brachial index</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
    <description>Diabetic patients with HbA1c&lt;9 who have wound 4 weeks or longer without infection with following interventions:
Finger prick test for HbA1c measurement
Punch biopsy
VAC sponge collection
Ankle brachial index</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Finger prick test for HbA1c measurement</intervention_name>
    <description>HbA1c measurement with finger prick method</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Punch Biopsy</intervention_name>
    <description>Wound site will be anaesthetized, by punch biopsy tissue will be collected, wound site will be monitored for bleeding(if bleeding Cautery will be used to stop bleeding).</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vac Sponge Collection</intervention_name>
    <description>NPWT sponge which is discarded as biological waste, will be collected for wound macrophage isolation</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ankle Brachial Index</intervention_name>
    <description>Blood pressure test</description>
    <arm_group_label>Diabetic patients infected ulcers</arm_group_label>
    <arm_group_label>Diabetic patients non infected Ulcers</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Wound Vac Sponge, Wound Tissue biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        28 diabetic subjects with chronic foot ulcer(s) that are receiving Negative Wound Pressure
        Therapy (NPWT) will be enrolled. 18 subjects will be infected and 10 subjects will be
        non-infected serving as the control for the study. The inclusion and exclusion criteria
        were carefully selected to enroll diabetic patients who have wound tissue oxygenation
        adequate to support wound healing.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18 - 70 years old

          2. Willing and able to provide informed consent

          3. Willing and able to comply with protocol instructions, including biopsies and study
             visits

          4. Diabetics with HbA1c ≤ 9

          5. Chronic (open ≥ 30 days) infected or non-infected foot ulcers Wagner grade 2-3

          6. Receiving Negative Wound Pressure Therapy (NPWT)

        Exclusion Criteria:

          1. Revascularization surgery on the target wound within 30 days prior to enrollment

          2. Inadequate arterial supply, as evidenced by any of the following (for wounds below the
             knee):

               1. TcOM &lt; 30mmHg

               2. ABI &lt; 0.7 or &gt; 1.3

               3. TBI &lt; 0.6

          3. Subjects with marked immunodeficiency (HIV/AIDS, organ transplant patients and
             actively being treated for cancer).

          4. Women who are pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sashwati Roy, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Hoover, LPN</last_name>
    <phone>614-293-0390</phone>
    <email>amy.hoover@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samir Zaparde, MD</last_name>
    <phone>614-313-4921</phone>
    <email>Samir.Zaparde@osumc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Ohio State University Hospital East</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hoover, LPN</last_name>
      <phone>614-293-0390</phone>
      <email>amy.hoover@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Samir Zaparde, BS</last_name>
      <phone>614-313-4921</phone>
      <email>samir.zaparde@osumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sashwati Roy, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehsive Wound Care Centers,The Ohio State University Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hoover, LPN</last_name>
      <phone>614-293-0390</phone>
      <email>amy.hoover@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Samir Zaparde, MD</last_name>
      <phone>614-313-4921</phone>
      <email>Samir.Zaparde@osumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sashwati Roy, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Davis Heart and Lung Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sashwati Roy, Ph.D</last_name>
      <phone>614-906-4612</phone>
      <email>sashwati.roy@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Amy Hoover, LPN</last_name>
      <phone>6142930390</phone>
      <email>amy.hoover@osumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sashwati Roy, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Martha Morehouse Medical Plaza</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Hoover, LPN</last_name>
      <phone>614-293-0390</phone>
      <email>amy.hoover@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Samir Zaparde, MD</last_name>
      <phone>614-313-4921</phone>
      <email>samir.zaparde@osumc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sashwati Roy, Ph.D`</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://medicalcenter.osu.edu/patientcare/healthcare_services/wound_care/Pages/index.aspx</url>
    <description>OSU Comprehensive Wound Center</description>
  </link>
  <link>
    <url>http://medicine.osu.edu/regenerativemedicine/Pages/index.aspx</url>
    <description>OSU Center for Regenerative Medicine and Cell based therapies</description>
  </link>
  <reference>
    <citation>Breen JD, Karchmer AW. Staphylococcus aureus infections in diabetic patients. Infect Dis Clin North Am. 1995 Mar;9(1):11-24. Review.</citation>
    <PMID>7769212</PMID>
  </reference>
  <reference>
    <citation>Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep. 2006 Dec;6(6):439-45. Review.</citation>
    <PMID>17118226</PMID>
  </reference>
  <reference>
    <citation>James GA, Swogger E, Wolcott R, Pulcini Ed, Secor P, Sestrich J, Costerton JW, Stewart PS. Biofilms in chronic wounds. Wound Repair Regen. 2008 Jan-Feb;16(1):37-44. Epub 2007 Dec 13.</citation>
    <PMID>18086294</PMID>
  </reference>
  <reference>
    <citation>Hanke ML, Angle A, Kielian T. MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection. PLoS One. 2012;7(8):e42476. doi: 10.1371/journal.pone.0042476. Epub 2012 Aug 3.</citation>
    <PMID>22879997</PMID>
  </reference>
  <reference>
    <citation>Hanke ML, Heim CE, Angle A, Sanderson SD, Kielian T. Targeting macrophage activation for the prevention and treatment of Staphylococcus aureus biofilm infections. J Immunol. 2013 Mar 1;190(5):2159-68. doi: 10.4049/jimmunol.1202348. Epub 2013 Jan 30. Erratum in: J Immunol. 2013 Jun 15;190(12):6709-10.</citation>
    <PMID>23365077</PMID>
  </reference>
  <reference>
    <citation>Neut D, Tijdens-Creusen EJ, Bulstra SK, van der Mei HC, Busscher HJ. Biofilms in chronic diabetic foot ulcers--a study of 2 cases. Acta Orthop. 2011 Jun;82(3):383-5. doi: 10.3109/17453674.2011.581265. Epub 2011 May 11.</citation>
    <PMID>21561305</PMID>
  </reference>
  <reference>
    <citation>Zhao G, Usui ML, Lippman SI, James GA, Stewart PS, Fleckman P, Olerud JE. Biofilms and Inflammation in Chronic Wounds. Adv Wound Care (New Rochelle). 2013 Sep;2(7):389-399. Review.</citation>
    <PMID>24527355</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>August 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2017</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Sashwati Roy</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Wound healing</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Inflammatory cells</keyword>
  <keyword>Macrophage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

